Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Randolph Martin

Cardiovascular Disease Atlanta, GA Medical Doctor

NPI 1578570321 CMS profile 207020

275 Collier Road, Nw, Suite 300, Atlanta, GA 30309

Open in the dashboard

General payments

$176,678

188 records reported · program years 2019–2025

Research payments

$15,261

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Randolph Martin of Atlanta, GA is reported in the CMS Open Payments database as having received $176,678 across 188 general payments and $15,261 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,440 17
2024 General $10,653 14
2023 General $35,180 31
2023 Research $8,900 1
2022 General $8,812 28
2021 General $7,000 2
2020 General $45,080 14
2020 Research $600 1
2019 General $66,514 82
2019 Research $5,761 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Randolph Martin
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Randolph Martin were reported at $3,440. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Randolph Martin Cardiovascular Disease median Middle half National median
2019 $66,514 $450 $127–$1,392 $163
2020 $45,080 $242 $77–$751 $114
2021 $7,000 $335 $101–$1,037 $132
2022 $8,812 $395 $121–$1,211 $149
2023 $35,180 $443 $136–$1,283 $160
2024 $10,653 $450 $136–$1,323 $164
2025 $3,440 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $83,025 114 payments
  2. Medtronic Vascular, Inc. $67,646 39 payments
  3. Caption Health, Inc. $15,101 1 payment
  4. Medtronic, Inc. $7,294 23 payments
  5. Abbott Laboratories $3,613 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $74,476 11 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,890 7 payments
  3. Travel and Lodging $31,705 79 payments
  4. Honoraria $6,250 2 payments
  5. Food and Beverage $5,357 89 payments
Products named General payments · program years 2019–2025
  1. CG Future $34,610 7 payments
  2. CoreValve Evolut $14,457 2 payments
  3. Tri-Ad $6,750 1 payment
  4. MITRIS RESILIA Mitral Valve $4,570 21 payments
  5. Contour 3D $4,500 1 payment
  6. MitraClip System $2,500 1 payment
  7. INSPIRIS RESILIA aortic valve $1,830 8 payments
  8. Mosaic $1,663 11 payments
  9. Mitra Clip system $988 7 payments
  10. Carpentier-Edwards Physio II Annuloplasty Ring $740 12 payments
  11. Other $477 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Caption Health, Inc. $8,900 1 payment
  2. Medtronic Vascular, Inc. $6,361 3 payments

Records

192 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record